SEPN Competitors & Alternatives
Compare Septerna, Inc. Common Stock with similar stocks in the same industry
Biotechnology
SEPN
Main Stock$36.57
Tradestie Score
58
Market Cap
$847.12M
Revenue Growth
120.1%
Analyst Upside
+25.2%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.83
|
$1.63B | - | 67 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.78
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$40.39
|
$1.56B | 94.1 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$87.53
|
$1.55B | - | 57 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.16
|
$1.55B | 13.5 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.19
|
$1.55B | - | 67 | Compare |
|
NVAX
Novavax Inc
|
$9.00
|
$1.54B | - | 54 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.88
|
$1.50B | 8.1 | 65 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.61
|
$1.50B | - | 57 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$16.37
|
$1.49B | - | 62 | Compare |
More SEPN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry